Pardi, Darrell S <br/><br/>
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.  [electronic resource] 

 -  Gastroenterology  Apr 2003 
 - 889-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0016-5085 
<br/><br/><label>Standard No.: </label>10.1053/gast.2003.50156  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aminosalicylic Acids--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Cholagogues and Choleretics--therapeutic use<br/>Cholangitis, Sclerosing--drug therapy<br/>Colitis, Ulcerative--drug therapy<br/>Colonic Neoplasms--epidemiology<br/>Disease-Free Survival<br/>Female<br/>Folic Acid--therapeutic use<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Risk Factors<br/>Ursodeoxycholic Acid--therapeutic use